The Cancer Letter

Inside information on cancer research and drug development

In Brief

Pharmacyclics receives award for Imbruvica

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
DOWNLOAD PDFTABLE OF CONTENTS

PHARMACYCLICS Inc. was awarded the 2014 Society for Medicines Research Award for Drug Discovery for its discovery of Imbruvica (ibrutinib). The award was presented by the Society of Medicines Research at its biennial award lecture in London.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

Table of Contents

Login

Site license subscribers:
Log in with your IP | Register a sponsored account